Aspect Imaging Ltd

Aspect Imaging Ltd develops advanced compact MRI systems, providing innovative imaging solutions for preclinical and clinical applications, enhancing diagnostic capabilities within various healthcare settings. Aspect Imaging Ltd specializes in compact MRI systems, founded in 2007 in Israel. The company has undergone significant developments in its business strategy. It has successfully raised USD 30 mn in funding over two deals, with the most recent round occurring in April 2017.

The firm has its headquarters in Israel, though specific global office locations are not detailed. No information is available regarding its founders or any companies they previously established. Aspect Imaging specializes in the development and manufacturing of compact MRI systems for both preclinical and clinical applications. Their flagship products include the M-Series compact MRI systems, utilizing a unique self-shielded permanent magnet design for high-resolution 3D imaging.

Notably, the Embrace® Neonatal MRI system allows critically ill infants to receive neuroimaging within the neonatal intensive care unit (NICU), which avoids the need for transport. These systems serve hospitals, research institutions, and academic facilities across North America, Europe, and Asia, enhancing MRI technology's efficiency and quality for diverse clients. Aspect Imaging's revenue model primarily revolves around the direct sale of MRI systems and associated services. Their transactions typically involve the purchase of systems like the M-Series and Embrace®, tailored to the specific needs of healthcare facilities and research institutions.

The B2B model is complemented by ongoing service and support contracts, ensuring optimal equipment functionality and maintenance, with pricing reflecting the advanced capabilities of their systems. Following a successful funding round in April 2017, Aspect Imaging Ltd plans to utilize the USD 30 mn raised to support the development of new products and enhance market presence. The company aims to introduce innovative MRI technologies while targeting expansion into emerging markets in Asia and Europe by 2025. The funding will facilitate these initiatives, driving their growth strategy and improving healthcare imaging solutions globally.